TLR Ligand-Based Solutions for Sustainable Agriculture and Environmental Remediation
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of toll-like receptor (TLR) ligands to develop novel applications in agriculture, environmental remediation, and biogas production, providing a sustainable and efficient solution for various industries.
Background and Problem Solved
The original patent focused on treating hepatic diseases and disorders. However, the limitations of this approach were its narrow application scope and lack of consideration for other industries. The new inventive concept addresses these limitations by applying the TLR ligand technology to tackle pressing issues in agriculture, environmental remediation, and biogas production, such as crop yield prediction, soil health improvement, bioremediation, disease detection in livestock, and biogas production efficiency.
Detailed Description of the Inventive Concept
The new inventive concept comprises a range of solutions utilizing TLR ligands to activate immune responses, stimulate beneficial microbial growth, and detect disease biomarkers. For instance, a system for monitoring and predicting crop yields uses a plant disease detection module with a TLR ligand to identify disease biomarkers in plant tissue. Similarly, a method for reducing environmental impact applies a pharmaceutical composition comprising a lysate and/or cell wall extract from a Gram-positive bacterium to soil, stimulating beneficial microbial growth and improving soil health. Other embodiments include a bioremediation system, a diagnostic kit for detecting diseases in livestock, and a method for improving biogas production efficiency.
Novelty and Inventive Step
The new claims introduce a paradigm shift by applying the TLR ligand technology to entirely new fields, including agriculture, environmental remediation, and biogas production. The inventive step lies in the recognition of the potential of TLR ligands to address pressing issues in these industries, and the development of novel solutions that leverage this technology.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include using different types of TLR ligands, modifying the composition and delivery of the pharmaceutical compositions, or integrating the TLR ligand technology with existing agricultural practices or biogas production methods. Variations could also include applying the technology to other industries, such as wastewater treatment or biofuel production.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the agriculture, environmental remediation, and biogas production industries. The market for sustainable agricultural practices, bioremediation solutions, and efficient biogas production is growing rapidly, and the TLR ligand-based solutions could capture a substantial share of this market. The technology could be licensed to companies operating in these industries, or Labyrinth Holdings, LLC could develop and market the solutions itself.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biotechnology and pharmaceutical sciences, with expertise in immunological receptor technologies, specifically toll-like receptor (TLR) and Nod-like receptor (NLR) activation systems for therapeutic and diagnostic applications
Person of Ordinary Skill (PHOSITA) Profile
A researcher or biotechnology professional with advanced degree (PhD or equivalent) in microbiology, immunology, or pharmaceutical sciences, possessing knowledge of receptor activation mechanisms, bacterial lysate technologies, and interdisciplinary applications of immunological modulators
Obviousness Rationale
The PTD represents a predictable extension of the source patent's core TLR ligand technology by applying the fundamental immunological activation mechanism to alternative domains. A PHOSITA would recognize that the underlying molecular principles of TLR/NLR activation are transferable across biological systems, making the agricultural and environmental applications a logical and obvious technological progression from the original hepatic disease treatment approach.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,577 |
|---|---|
| Title | Compositions and methods for the treatment of hepatic diseases and disorders |
| Assignee(s) | Labyrinth Holdings, LLC |